Data quality is a vital attribute in determining the usability and productivity of electronic patient records systems. Evidence is presented that suggests that primary healthcare teams participating in a project offering training and support in the use of information systems have succeeded in achieving improvement in the quality of the data accumulated in their computerised records systems.
Introduction
PRIMIS (Primary Care Information Services) is a training and support programme commissioned by the National Health Service Information Authority (NHSIA) to facilitate general practice teams in England in their use of computerised patient records systems. 1 The project commenced in April 2000 after being piloted for three years as the CHDGP (Collection of Health Data from General Practice) project. 2 At the time of writing this paper, training and support are cascaded from the PRIMIS team at the University of Nottingham through over 250 local information facilitators to around 3000 practices in over 220 primary care trusts (PCTs). These data are necessarily estimates as the project is still in progress and recruitment of PCTs, facilitators and practices is continuing.
The current major focus of PRIMIS training and support is the achievement of maximal data quality as an essential prerequisite to reliable and effective exploitation of 'value added' clinical system capabilities (such as electronic communication, clinical audit, decision support, office automation, etc.). Participating practices are encouraged to evaluate the quality of their recorded data by provision of facilitated feedback of selected clinical data extracted from their clinical records system. For comparative purposes, practices are also given access to equivalent anonymised feedback using data from peer practices in their locality. Extracted data are analysed and fed back using an analysis and display tool, 'Rush' , developed in Microsoft Excel. Apparent deficiencies or anomalies in extracted data are examined in facilitated discussion and used as the basis for determining remedial initiatives retrospectively to correct erroneous data and also prospectively to improve clinical data recording practice. Practices are encouraged to undertake a second cycle of data extraction and analysis in order to assess the effect of their actions in response to this programme.
In addition to the data quality analyses described above, practices are also invited to participate in a comparative analysis programme reflecting national clinical initiatives (for instance, national service frameworks) and also nationally recognised clinical guidelines (such as the British Thoracic Society guidelines for the management of asthma). 3,4 A similar programme of data extraction, analysis and feedback is implemented to provide practices with information about the data they have recorded in response to such initiatives, with the objective of encouraging improvement in clinical data recording practice. It is anticipated that this activity will, indirectly, result in improved clinical practice through providing improved access to relevant information.
PHCSG Annual Conference papers
Trends in data recording by general practice teams: an analysis of data extracted from clinical computer systems by the PRIMIS project This paper describes a time trend analysis of various data accumulated in support of these activities during the first two years of the project (April 2000 to April 2002). Data were selected for analysis on the basis of being derived to the same specification from the same practice on two consecutive occasions. The analysis was undertaken primarily for the purpose of evaluating the effectiveness of the PRIMIS project in stimulating improvement in data quality among participating practices.
Methods
Clinical data are extracted from clinical computer systems using MIQUEST (a generic data extraction tool) and anonymously aggregated by the PRIMIS team. 5 Extraction of data has been undertaken to various specifications to enable analyses in support of a range of functions as follows: data quality analysis: -prevalence of common morbidities (for example, diabetes mellitus, hypertension, ischaemic heart disease) -'apparent prevalence' analyses: these are designed to assess completeness of diagnostic recording. The assessment is achieved by comparison of the recording of diagnostic codes with an indicative prevalence derived using both diagnostic and proxy codes (such as prescription of insulin as a proxy for the diagnosis of diabetes). Hence if diagnostic coding is complete it should equal 100% of the indicative prevalence -recording of screening data (for instance, smoking status and alcohol consumption) -gender discrepancies (such as recording of hysterectomy procedures in male patients) comparative analysis relating to specific clinical conditions and syndromes: -ischaemic heart disease -hypertension -epilepsy -asthma -severe mental illness These comparative analyses have been specified to examine various features of clinical care: -prevalence of the target condition(s) -recording of aspects of clinical management (for example, HbA1c in patients with diabetes mellitus) -recording of screening procedures in the general population (such as blood pressure screening) -prescribing and other therapeutic interventions -recording of comorbidities (for instance, hypertension in patients with ischaemic heart disease) -proxy outcomes (for example, control of blood pressure in hypertensive patients).
Extracted data are returned by practices to the PRIMIS team and compiled into a single master database prior to further processing in order to produce feedback in both graphical and tabular form. The data accumulated in that database have been used as the substrate for the analyses described in this report. A software routine for exporting data from the database into Microsoft Excel was developed. The routine enabled identification of instances where an individual practice had returned responses to the same specified MIQUEST enquiry on two separate occasions with an interval of at least three months. Data satisfying this criterion were exported to Excel for further processing. At this point the data were charted and visually assessed to identify instances of extraction failure. An example illustrating this is included as Figure 1 , in which data from the first and second extraction cycles are labelled 'Wave 1' and 'Wave 2' respectively. It can be seen that a number of practices have returned zero prevalence in the second extraction, despite having non-zero returns in extraction one. This was taken to be de facto evidence of extraction failure (on the basis that it is barely credible that a practice should delete all instances of a previously recorded and common morbidity).
Where there was such evidence of failure, the data concerned were excluded from further analysis. Data including returns from fewer than 50 practices (an ad hoc criterion) were also excluded from analysis. Statistical analyses of the resulting data were undertaken in SPSS 10.0 for Windows using Wilcoxon's signed ranks test. In these analyses a P value , 0.01 has been taken to indicate statistical significance. In addition, a visual assessment of the charted data (see Figures 1, 2 and 3) was undertaken to enable qualitative evaluation of any change.
Results
Results of analysis of 38 paired extractions of data from between 51 and 347 practices are presented. Table 1 lists the types of data that have been analysed, and Table 2 details the results of the analyses.
Using the groupings in Table 1 , the significant features demonstrated by the analyses within each category are outlined below.
Raw prevalence data
All of these analyses reveal evidence of statistically significant change in recorded prevalence. In each instance the change takes the form of an increase in the mean recorded prevalence of between 0.1 and 2.0 percentage points. In all 11 analyses there is also visual evidence on inspecting the charted data (illustrated by Figures 1, 2 and 3 ) that the increase in prevalence is more pronounced at the left end of the curve (that is, concentrated in the group where the lowest prevalences were recorded in the first extraction cycle). This is suggestive evidence of appropriate 'catch up' recording of morbidity by practices with initial recording rates that are lower than those of peer organisations. This interpretation is partly based on an assumption that, where increased morbidity recording is evident, it has occurred as a result of improved recording of pre-existing disease. The PRIMIS team acknowledges that it is possible that these increases in recorded morbidity may also result from changing epidemiological patterns. If this were true, then to attribute the increase to improvement in data quality would be erroneous. However, given the known stability of epidemiological patterns in the time frames addressed by this study, it is the considered view of the PRIMIS team that this alternative interpretation is highly unlikely to be correct. It is also possible that the changes seen may be a consequence of incorrect recording of diagnostic data, that is, a deterioration in data quality. In the absence of a suitable 'gold standard' against which a definitive comparison can be made, these alternative interpretations cannot be disproved. Nevertheless the PRIMIS team considers that these data are entirely consistent with the assertion that recording of morbidity Recording of process data in the management of chronic conditions 10
Recording of screening data in the general population 3
Recording of therapeutic intervention in chronic conditions 7
Total 38 has improved in the population of practices that are the subject of this study. Four of the 11 analyses (diabetes, hypertension, ischaemic heart disease and currently active asthma) betray evidence of possible data corruption as part of the extraction process. In each instance a small cluster of practices have returned unusually high prevalences in the second data extraction cycle (illustrated in Figure 3) . Examination of the source data suggests that this results from incomplete data about the size of the practice population. Because the anomalies identified involve partial rather than complete loss of data, and because variation in practice populations is inevitable, it has not proved possible to derive a satisfactory rule of thumb to determine which of these data might justifiably be excluded from analysis. However, ad hoc re-analyses of these data excluding the 'worst five' cases with the highest prevalence rates has not resulted in loss of statistical power.
Comorbidity recording
Both of these analyses reveal evidence of significant change in recording of two comorbidities -diabetes and hypertension -in patients with ischaemic heart disease. The change is represented by an increase in the mean comorbidity rate of 1.15 and 4.67 percentage points respectively. In both instances there is a clear visual impression from charted data that the increase is most pronounced in practices with lower initial comorbidity rates. This is again strongly suggestive of appropriate 'catch up' capture of previously unrecorded data.
In contrast to the raw prevalence analyses, there is little evidence in these analyses to suggest that the data have been corrupted or are incomplete.
'Apparent prevalence'
In two of the five apparent prevalence analyses, the comparisons of recorded prevalences with indicative prevalences of hypertension and of severe mental illness, there is a significant shift towards the ideal of 100%. The change observed with hypertension is quite small, an increase of only 0.3 percentage points in a mean which is already high at 94.61%. This overall picture reflects the fact that the analysis is known to be relatively insensitive in assessing recording of hypertension because of the small number of reliable proxies available for this diagnosis. By contrast, there are numerous strong proxies for severe mental illness and the pronounced positive shift in this instance is considered to be good evidence of data quality improvement. Of the remaining three apparent prevalence analyses, the comparison of recorded and indicative prevalence of asthma has shown a significant reduction. At first sight this might be considered evidence of deterioration in data quality. However, the effect is highly likely to result from an increasing trend towards the use of bronchodilator medication for symptomatic relief in patients who do not have asthma and therefore cannot reliably be interpreted as a deterioration. Apparent prevalence analyses of diabetes mellitus and ischaemic heart disease have not revealed any significant change.
Recording of process data in the management of chronic conditions
These ten analyses examine the recording of process data during the one-year period before data extraction in subpopulations of patients with chronic conditions. Seven of the ten reveal evidence of significant improvement in recording rates. In those seven analyses, increases in recording rates of between four and 15 percentage points have been demonstrated.
Focusing as they do on recording of data during the year prior to data extraction, these ten analyses represent a particularly stringent measure of the completeness of data recording. In addition, these improvements have taken place against a background of an increasing denominator, as demonstrated in the analyses of prevalence of the denominator conditions described above. Hence the improved completeness of recording of process data is of even greater import.
Visual assessment of data in this group reveals some minor evidence of possible data corruption. There are a few instances of recording rates reported as exceeding 100% and some instances of marked reduction in rates between Wave 1 and Wave 2 which may be indicative of incomplete data extraction. These anomalies alone are not considered sufficient to cast serious doubt on the analyses undertaken but their presence must be acknowledged.
Recording of screening data in the general population
These three analyses of recording of general screening data are based on data recorded at any time. Two of the three analyses reveal changes that achieve statistical significance, but in each instance the increase in the mean level of recording is modest, ranging between 0.99 and 1.27 percentage points. This contrasts markedly with the visual impression of the charted data which suggests that many practices have achieved large increases in their recording rates. However, there are also many practices where a large reduction is evident, with the implication that much of the source data may be incomplete (for example, as the extraction includes data recorded at any time, it is barely plausible that a practice returning 65% recording of alcohol consumption in the first cycle should slump to 15% in the second cycle other than as a result of incomplete data extraction).
The third of these analyses, that of body mass index recording, reveals a small (0.45%) but significant decrease in recording levels. The reasons for this unexpected result have not been determined but incomplete data extraction cannot be ruled out as a possible cause.
Recording of treatment prescribed in the management of chronic conditions
In this group, six of seven analyses have revealed significant improvements in the numbers of patients recorded as receiving specific treatments. The increases in observed means range between 3.94 and 11.85 percentage points. The remaining analysis (treatment with a salicylate of patients recorded as having a history of myocardial infarction) demonstrates an increase which just fails to achieve statistical significance, whereas the same analysis in patients with a record of ischaemic heart disease returns a significant result. It is possible that insufficient data have been achieved to enable this analysis to achieve significance.
Discussion
The interpretation of the analyses presented in this report and reliability of any conclusions drawn would be enhanced had it been possible to undertake comparison with equivalent control data from practices not participating in the PRIMIS project. However, the PRIMIS team was unable to devise a sustainable method of achieving access to suitable control data as this is outside the scope of the project as currently constituted. The work described in this report is therefore observational in nature. Within that constraint the report presents evidence of changes over time in data recorded by primary healthcare teams using clinical computer systems. Thirty-two out of 38 sets of data have revealed significant change after exclusion of small quantities of data deemed to be inaccurate.
The increases demonstrated in completeness of recording of process data in chronic conditions and completeness of recording of screening data, both represent progress towards a theoretical ideal of 100%. As such, they constitute prima facie evidence of increased completeness and hence of data quality improvement. Similarly the improvement in treatment records indicates appropriate use of prescribing facilities and probably also represents an appropriate increase in intervention rates.
The changes demonstrated in raw prevalence and comorbidity recording require more careful interpretation. In the absence of a 'gold standard' for comparison it is not possible to be certain whether or not the observed changes represent data quality improvement. However, the observable features of the changes demonstrated in these analyses (migration towards a mean which is consistent with expectation and 'catch up' recording at the lower end of the range) are strongly suggestive of improved quality of data.
Contrary to expectations, the 'apparent prevalence' analyses have not provided persuasive evidence of improved internal consistency of data. The reasons for this are unclear and will be the subject of further research by the PRIMIS team. The concept underpinning these analyses is that of proxy diagnoses: non-diagnostic codes that are sufficiently specific to an identified clinical condition to be indicative of the presence of that condition. It is possible that the proxies used have not been sufficiently robust to adequately support such interpretation.
There are uncertainties about the completeness and reliability of some of the data that have been presented. In the current environment of primary care clinical computing this is, unfortunately, unavoidable. MIQUEST, the data extraction tool used by PRIMIS, is known not to be entirely reliable. It is, however, the only data extraction tool currently available that is suitable for this task. The considered view of the PRIMIS team is that any unreliability in the data presented in these analyses is unlikely to be of a magnitude which will render the conclusions unsustainable. However, any conclusions drawn must, necessarily, be interpreted in the light of this caveat.
Conclusions
1 The data presented in this paper provide clear quantitative evidence that patterns of recording of clinical data by practices involved in the PRIMIS project have changed during the course of the project. 2 Where change has been demonstrated, in many instances it can be directly interpreted as providing evidence of improved data quality. 3 The remaining analyses that demonstrate change, while not being directly interpretable as evidence of data quality improvement, are entirely consistent with improved data quality.
4 At the time of writing, implementation of the MIQUEST data extraction utility in clinical systems is of variable quality. This hinders reliable access to aggregated clinical data and thus impedes full exploitation of the potential benefits of electronic patient records systems. Action is needed to ensure that reliable MIQUEST interpreters are made available on a consistent basis at least until adequate alternative data extraction utilities are available.
